NCT04930614 Prevalence and Risk Factors of HIV Infections in Transgender and Non-binary People in Flanders and Brussels (Belgium) Status COMPLETED Phase N/A
NCT04925752 Study of Lenacapavir for HIV Pre-Exposure Prophylaxis in People Who Are at Risk for HIV Infection Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT04892446 Study of Magrolimab Combinations in Patients With Relapsed/Refractory Multiple Myeloma Status TERMINATED Phase PHASE2
NCT04891770 Study to Evaluate the Safety and Efficacy of Selgantolimod (SLGN)-Containing Combination Therapies for the Treatment of Chronic Hepatitis B (CHB) Status COMPLETED Phase PHASE2
NCT04880577 Tenofovir Alafenamide for Treatment of Symptoms and Neuroprotection in Relapsing Remitting Multiple Sclerosis Status WITHDRAWN Phase PHASE2
NCT04873609 Electronic Record Assimilation and Subsequent Eradication of Hepatitis C Status COMPLETED Phase NA
NCT04868864 The Ontario Multi-Regional Hospital COVID-19 Registry (COREG)- Recovery Trajectory Sub-study Status UNKNOWN Phase N/A
NCT04863885 Combination of Ipi/Nivo Plus Sacituzumab Govitecan in Metastatic Cisplatin Ineligible Urothelial Carcinoma Patients Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT04854499 Study of Magrolimab Combination Therapy in Patients With Head and Neck Squamous Cell Carcinoma Status TERMINATED Phase PHASE2
NCT04847622 Study to Evaluate the Clinical Outcomes in Adults With Covid-19 Who Have Been Treated With Remdesivir. Status COMPLETED Phase N/A
NCT04843761 ACTIV-3b: Therapeutics for Severely Ill Inpatients With COVID-19 Status COMPLETED Phase PHASE3
NCT04827589 Study to Evaluate the Efficacy, Safety, and Tolerability of Tirabrutinib in Participants With Antihistamine-Resistant Chronic Spontaneous Urticaria Status WITHDRAWN Phase PHASE2
NCT04811040 Study to Evaluate the Safety and Efficacy of Teropavimab and Zinlirvimab in Combination With Lenacapavir in Virologically Suppressed Adults With HIV-1 Infection Status COMPLETED Phase PHASE1
NCT04809623 Study of Edecesertib in Participants With Cutaneous Lupus Erythematosus (CLE) Status TERMINATED Phase PHASE1
NCT04778410 Study of Magrolimab Combinations in Participants With Myeloid Malignancies Status TERMINATED Phase PHASE2
NCT04778397 Study of Magrolimab in Combination With Azacitidine Versus Physician's Choice of Venetoclax in Combination With Azacitidine or Intensive Chemotherapy in Patients With TP53 Mutant Acute Myeloid Leukemia That Have Not Been Treated Status TERMINATED Phase PHASE3
NCT04772989 A Study to Evaluate AB308 in Combination With AB122 in Participants With Advanced Malignancies Status COMPLETED Phase PHASE1